Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
20.30
-0.37 (-1.79%)
Aug 1, 2025, 11:18 AM - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $652.85 million as of August 1, 2025. Its market cap has decreased by -21.95% in one year.
Market Cap
652.85M
Enterprise Value
334.60M
1-Year Change
-21.95%
Ranking
Category
Stock Price
$20.30
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $652.85M, an increase of 300.53%. That is a compound annual growth rate of 108.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 664.75M | 3.03% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |